Bill > HR3282

This bill aims to promote transparency and healthy competition in the Medicare program under Parts C (Medicare Advantage) and D (Prescription Drug Coverage). It requires Medicare Advantage organizations and Prescription Drug Plan (PDP) sponsors to report detailed information about their relationships with healthcare providers, pharmacies, and pharmacy benefit managers (PBMs). This includes data on the volume of services, diagnoses, risk scores, prior authorization requests, and financial arrangements between these entities. The bill also mandates that PDP sponsors only contract with PBMs that agree to disclose information about rebates, payments to pharmacies, and administrative costs. The Secretary of Health and Human Services is required to establish a process to publicly disclose the reported information by January 1, 2027, while protecting the confidentiality of specific drug prices and other sensitive data.